Opsens Inc

Entity type image
Type: Company
Name: Opsens Inc
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

CVTech appoints Rochette to board

CVTech Group Inc.'s board of directors has approved the appointment of Jean Rochette as a member of the board. The appointment, which fills a vacant seat, is effective immediately.Mr. Rochette has extensive experience in corporate management. He is currently ... [Published Stockwatch - Apr 29 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports
Celestica Inc
Celestica Inc

Canadian earnings declared Tuesday: Celestica, Opsens, Mart Resources, Teck Resources, TransAlta, Encana

TORONTO - Canadian earnings declared Tuesday:Celestica inc. (TSX:CLS): First-quarter ended March 31, 2013, US$10.5 million, six cents per diluted share; 2012, US$43.2 million, 20 cents per share. Revenue: 2013, US$1.37 billion; 2012, US$1.69 billion.Encana ... [Published Brandon Sun - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Opsens loses $623,000 in Q2 2013

Opsens Inc. has released the results for its second quarter ended Feb. 28, 2013. Second Quarter 2013 Highlights Largest oil and gas order received to date:48 OPP-W systems;Verification and Validation phase continues for Opsens' OptoWire for Fractional ... [Published Stockwatch - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Opsens reports second quarter 2013 results CNW Group

/CNW Telbec/ - Opsens Inc. ("Opsens") (OPS.V) today released results for its second quarter ended February 28, 2013 . "The net result and gross margin improved during this quarter, reflecting our focus on higher value markets. Opsens' revenues decreased ... [Published Yahoo! Finance - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports
Toronto stock exchange
Toronto stock exchange

Opsens reports second quarter 2013 results

Canada NewsWireQUEBEC CITY, April 23, 2013 QUEBEC Second Quarter 2013 Highlights "The net result and gross margin improved during this quarter, reflecting our focus on higher value markets. Opsens' revenues decreased in the last quarter, as some oil and ... [Published Digital Journal - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Opsens reports second quarter 2013 results

Opsens Inc. ("Opsens") (TSXV: OPS) today released results for its second quarter ended February 28, 2013.Second Quarter 2013 Highlights"The net result and gross margin improved during this quarter, reflecting our focus on higher value markets. Opsens' ... [Published Scottrade - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Opsens reports second quarter 2013 results

/CNW Telbec/ - Opsens Inc. ("Opsens") (TSXV: OPS) today released results for its second quarter ended February 28, 2013.Second Quarter 2013 Highlights$ Largest oil and gas order received to date: 48 OPP-W systems; Verification and Validation phase continues ... [Published Canada NewsWire - Apr 23 2013]
First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

OPSENS INC.: Opsens participates in goldman sachs emerging healthcare series

"We are very pleased to present at Goldman Sachs and appreciated the venue afforded to us to discuss the promising market opportunities for a third player in the fast-growing FFR market. The Company has made significant progress towards our goal of providing ... [Published 4 Traders - Apr 19 2013]
First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Opsens participates in Goldman Sachs Emerging Healthcare Series highlights FFR market and Company's technology

/CNW Telbec/ - Opsens Inc. ("Opsens") (TSXV: OPS) is pleased to announce that the Company participated to the most recent Emerging Healthcare Series hosted by Goldman Sachs.$ $ As part of the presentation, Louis Laflamme, CEO, discussed the market for ... [Published Canada NewsWire - Apr 19 2013]
First reported Mar 12 2013 - Updated Mar 12 2013 - 1 reports

Opsens wins contract for 48 OPP-W sensors

Opsens Inc. has been awarded its most single significant contract to date, to supply and install 48 OPP-W sensor systems in an Alberta SAGD (steam-assisted gravity drainage) oil sands project.The contract has been placed by an oil and gas producer with ... [Published Stockwatch - Mar 12 2013]
First reported Feb 20 2013 - Updated Feb 20 2013 - 1 reports

Opsens installs OPS-Z technology for Aquistore project

Opsens Inc. has successfully deployed and installed its patented OPS-Z pressure and temperature technology, on the Petroleum Technology Research Centre (PTRC) Aquistore CO2 (carbon dioxide) storage and monitoring project in Saskatchewan, Canada.PTRC had ... [Published Stockwatch - Feb 20 2013]
First reported Nov 26 2012 - Updated Nov 26 2012 - 1 reports

Monday Deal Review: November 26, 2012

Welcome to your Monday Biotech Deal Review for November 26, 2012. This past week saw Valeant continue their aggressive stock repurchase program. Valeant plans to repurchase up to $1.5 billion worth of its own stock, senior notes or debt. Further, we ... [Published The Cross-Border Biotech Blog - Nov 26 2012]

Quotes

"On behalf of all board members, I congratulate Mr. Rochette for his appointment and extend to him a most cordial welcome. His recognized leadership qualities, professionalism and ability to develop a strategic vision make Mr. Rochette a judicious choice. We are enthusiastic at the idea of benefiting from his talent and his experience" said Jacques Joly, chairman of the boardboard of directors of CVTech
CVTech appoints Rochette to board [Published Stockwatch - Apr 29 2013]
"The net result and gross margin improved during this quarter, reflecting our focus on higher value markets. Opsens' revenues decreased in the last quarter, as some oil and gas installations were carried over to the next quarters. We expect increased revenues in the remaining portion of our 2013 fiscal year, as the backlog already reflects a sustained growth with an increase in OPP-Ws sales" said Louis Laflamme, President and CEO of Opsens
Opsens loses $623,000 in Q2 2013 [Published Stockwatch - Apr 23 2013]
Laflamme continued "as for the medical instrumentation segment, the commercial release of the OptoWire, scheduled for 2014, is approaching rapidly. Opsens is anxious to enter the fast growing FFR market which reached $207 million"
Opsens reports second quarter 2013 results [Published Digital Journal - Apr 23 2013]
"We are very pleased to present at Goldman Sachs and appreciated the venue afforded to us to discuss the promising market opportunities for a third player in the fast-growing FFR market. The Company has made significant progress towards our goal of providing our FFR product line worldwide and we look forward to detailing further updates to our shareholders throughout the year" stated Louis Laflamme, CEO...
OPSENS INC.: Opsens participates in goldman sachs emerging healthcare series [Published 4 Traders - Apr 19 2013]

More Content

All (13) | News (12) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
CVTech appoints Rochette to board [Published Stockwatch - Apr 29 2013]
CVTech Group Inc. announces the appointment of ... [Published Canada NewsWire - Apr 29 2013]
Canadian earnings declared Tuesday: Celestica, ... [Published Brandon Sun - Apr 23 2013]
Opsens loses $623,000 in Q2 2013 [Published Stockwatch - Apr 23 2013]
Opsens reports second quarter 2013 results CNW ... [Published Yahoo! Finance - Apr 23 2013]
Opsens reports second quarter 2013 results [Published Digital Journal - Apr 23 2013]
Opsens reports second quarter 2013 results [Published Scottrade - Apr 23 2013]
Opsens reports second quarter 2013 results [Published Canada NewsWire - Apr 23 2013]
OPSENS INC.: Opsens participates in goldman sac... [Published 4 Traders - Apr 19 2013]
Opsens participates in Goldman Sachs Emerging H... [Published Canada NewsWire - Apr 19 2013]
Opsens wins contract for 48 OPP-W sensors [Published Stockwatch - Mar 12 2013]
Opsens installs OPS-Z technology for Aquistore ... [Published Stockwatch - Feb 20 2013]
Monday Deal Review: November 26, 2012 [Published The Cross-Border Biotech Blog - Nov 26 2012]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Monday Deal Review: November 26, 2012 [Published The Cross-Border Biotech Blog - Nov 26 2012]
Welcome to your Monday Biotech Deal Review for November 26, 2012. This past week saw Valeant continue their aggressive stock repurchase program. Valeant plans to repurchase up to $1.5 billion worth of its own stock, senior notes or debt. Further, we ...
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.